With Activist Investors Looming, Genzyme Takes Preventive Steps
Executive Summary
An eventful week at Genzyme concluded with two developments that could keep activist investors and the potential for a proxy fight at bay - a mutual cooperation agreement with a top institutional investor and the hiring of a senior vice president of global product quality